Can we provide our own donor fecal material?

Yes. Clients may supply fresh or cryopreserved donor material processed under anaerobic conditions, or we can source curated human donor samples. The input inoculum is profiled by 16S sequencing and archived before use.

Humanized Microbiome Mouse Models for Translational Microbiome Research

Q: What is the difference between a germ-free mouse and an antibiotic-conditioned mouse for humanized microbiome studies?

Germ-free (GF) mice harbor no microorganisms and provide complete microbial control, ideal for causality and mechanistic studies. Antibiotic-conditioned mice have a residual microbiome after depletion and offer faster setup for efficacy screening. Both receive human donor FMT to establish a humanized microbiome colonization background.

Q: How long does a typical study take from start to data delivery?

A standard study runs 10 to 16 weeks from project kickoff to final report delivery. Shorter exploratory designs can be completed in 6 to 8 weeks. Timelines are confirmed at project scoping.

The Translational Gap — and How We Close It

SPF mouse models carry a rodent-derived microbiome that does not reflect human gut ecology. For microbiome research programs — LBPs, dietary interventions, or microbiome-modulating drugs — this mismatch is a core source of preclinical-to-clinical failure. Humanized microbiome mouse models, established via FMT into germ-free or antibiotic-conditioned mice, provide a more human-relevant microbial background for in vivo efficacy testing and mechanistic studies.

16S & WGS

Colonization verified at community level by sequencing; QC report issued before study proceeds.

GF + ABX

Both germ-free and antibiotic-conditioned platforms available to match your study design and budget.

Full Report

Colonization quality report, efficacy endpoint data, and study design recommendations delivered.

SPF data not translating?

Rodent-specific microbiomes make results hard to interpret in a human disease context.

Uncertain colonization stability?

Without sequencing-based QC, community drift goes undetected and invalidates results.

No gnotobiotic facility in-house?

GF infrastructure requires specialized isolators and maintenance most research groups cannot support.

Our Humanized Microbiome Mouse Model Services

Core scope covers model preparation, colonization QC, in vivo efficacy testing, and biospecimen collection. Advanced readouts are available as optional add-ons.

Core Service Scope

Germ-Free / Antibiotic-Conditioned Mouse Preparation

We prepare germ-free (GF) mice maintained in sterile isolators, or antibiotic-conditioned mice where a fully germ-free platform is not required. GF models provide a blank-slate host for controlled human microbiome colonization; antibiotic-conditioned models offer a practical alternative with faster setup. Both serve as the in vivo recipient for human donor FMT.

Human Donor FMT Colonization

Human donor fecal material is processed anaerobically to preserve viability, then administered to recipient mice by oral gavage. Clients may supply their own donor material or request curated donor samples. FMT route, dose, and timing are optimized per study design to support consistent engraftment across cohorts.

Colonization QC by 16S Sequencing

Post-engraftment fecal samples are profiled by 16S rRNA gene sequencing. QC metrics include alpha-diversity, donor-recipient community similarity (Bray-Curtis), and absence of contamination. A colonization quality report is issued before the study enters the treatment phase. Shotgun metagenomics is available as an upgrade for strain-level or functional resolution.

Efficacy Endpoint Evaluation

The humanized microbiome mouse model serves as the in vivo test platform for your study article — LBPs, prebiotics, small molecules, or other microbiome-modulating agents. Standard endpoint categories include gut barrier integrity, host immune markers, short-chain fatty acid profiles, and inflammatory readouts. Endpoints are defined at project scoping.

Key Biospecimen Collection

Structured collection of fecal pellets, cecal contents, blood, and intestinal tissue at defined study time points. Samples are aliquoted and archived at -80℃ for the agreed-upon retention period, allowing follow-on analyses without repeating the animal study.

Study Report, Experimental Design & Statistical Recommendations

Every study closes with a written report: colonization quality data, endpoint results, statistical analysis, and design recommendations for follow-on work. Reports are structured for internal review and downstream research decision-making.

Optional Advanced Add-ons

Shotgun Metagenomics

Strain-level resolution and functional pathway analysis of colonized communities.

Metabolomics

SCFA profiling, bile acid panels, and targeted metabolite analysis from cecal or serum samples.

Host Immune Profiling

Cytokine multiplex panels, flow cytometry, secretory IgA, and mucosal immune readouts.

Histopathology

Intestinal tissue H&E staining, tight junction protein scoring, and lesion assessment.

Multi-omics Integration

Combined analysis linking microbiome data to host molecular readouts for mechanistic support.

Gut Permeability Assay

FITC-dextran barrier integrity test to quantify intestinal permeability changes.

Humanized Microbiome Mouse Model Study Workflow

Each stage gated by defined QC checkpoints. No study proceeds to treatment without confirmed colonization.

1

Project Scoping

Define model type, donor criteria, endpoints, and timeline. Statistical plan agreed upfront.

2

FMT Preparation

Donor material processed anaerobically; inoculum profiled by 16S/WGS and archived.

3

Mouse Colonization

GF or antibiotic-conditioned mice colonized by oral gavage; engraftment monitored at days 7 and 14.

4

Colonization QC Gate

16S-based QC report issued. Study only advances when engraftment meets defined thresholds.

5

Treatment & Endpoint Collection

In vivo dosing and longitudinal fecal + tissue collection per protocol.

6

Analysis & Report Delivery

Colonization quality report, endpoint data, statistical outputs, and design recommendations delivered.

Deliverables and Model Selection Guide

Defined deliverables for every humanized microbiome mouse study — no ambiguity about what you get.

Deliverable	What Is Included
Colonization Quality Report	Alpha/beta diversity metrics, donor-recipient similarity (Bray-Curtis), temporal stability, per-cohort QC pass/fail summary
16S Sequencing Dataset	Raw FASTQ files + processed OTU/ASV tables; relative abundance profiles at genus and family level
Efficacy Endpoint Data	Immune markers, SCFA results, histology scores, or other pre-agreed endpoint data with tabulated results
Statistical Analysis	Pre-specified statistical tests, between-group comparisons, effect size estimates, and interpretation notes
Design Recommendations	Written recommendations for follow-on studies based on colonization performance and endpoint outcomes
Archived Biospecimens	Fecal pellets, cecal contents, serum, and tissue aliquots retained at -80℃ for the agreed retention period

Which model fits your project?

Factor	GF / Gnotobiotic	Antibiotic-Conditioned
Microbial control	Complete	Partial
Setup complexity	Higher	Lower
Best for	Causality, MoA	Efficacy screening
Colonization QC	Mandatory	Mandatory

Not sure which platform fits?

Tell us your test article and indication — we will recommend the right model and scope.

Why Work with Creative Biolabs

What separates a well-run humanized microbiome study from an inconclusive one is not the FMT itself — it is the QC rigor, endpoint design, and reporting that surrounds it.

Mandatory Colonization QC Gate

No study proceeds to treatment without a passing sequencing-based colonization report. Community drift is identified and remediated before dosing begins.

Defined Service Scope

Core deliverables and optional add-ons are clearly separated. You know exactly what is included before work begins — no scope creep or unclear outputs.

In-House Bioinformatics

16S and metagenomic analysis is performed in-house, with interpretable outputs — not raw files — delivered alongside statistical support aligned to your study questions.

Modular Add-on Design

Advanced readouts — metabolomics, immune profiling, histopathology — can be added to core studies without redesigning the entire experiment.

Archived Samples for Follow-on Work

All biospecimens are retained at -80℃, enabling future analyses from the same animal cohort without repeating the in vivo study.

Dedicated Project Management

A scientific project manager coordinates across gnotobiotic, sequencing, and endpoint teams throughout the study — one contact point for updates and decisions.

Published Data: Humanized Gnotobiotic Mouse Models in Translational Microbiome Research

Workflow for establishing a humanized gnotobiotic mouse model. (Creative Biolabs Authorized) — Fig.1 Schematic diagram of creating a humanized gnotobiotic mouse model.^1,2

Published studies support the use of germ-free and gnotobiotic mice colonized with human donor microbiota as a valuable platform for translational microbiome research. Compared with conventional SPF mice, these models provide a more human-relevant microbial background for evaluating microbiome-targeted therapeutics, dietary interventions, and host–microbiome interactions.

Key methodological considerations highlighted in the literature include donor selection, anaerobic handling of inocula, recipient background, and sequencing-based verification of colonization. These factors are critical for achieving reproducible engraftment and generating interpretable in vivo results.

Creative Biolabs incorporates these principles into its humanized microbiome mouse model workflow through controlled FMT colonization, 16S or shotgun metagenomic QC, efficacy endpoint assessment, and structured study reporting.

Related Services

Humanized microbiome mouse models are most effective when combined with complementary preclinical and sequencing services. The following are frequently used alongside this service:

Fecal Microbiota Transplants (FMT)

FMT preparation and administration for preclinical model colonization studies.

Germ-Free Mouse Model Testing

Axenic mouse maintenance and gnotobiotic colonization platform access.

Mammalian Animal Models for LBP Assessment

Broader mammalian in vivo platform for LBP safety and efficacy evaluation.

Zebrafish Model Drug Efficacy Evaluation

Cost-effective zebrafish platform for early-stage microbiome efficacy screening.

16S rDNA Sequencing and Microbe Identification

Taxonomic community profiling for colonization QC and microbiome characterization.

Shotgun Metagenomics Sequencing

Whole-metagenome sequencing for strain-level resolution and functional profiling.

Frequently Asked Questions

Germ-free (GF) mice harbor no microorganisms and are maintained in sterile isolators, providing complete microbial control — ideal for causality studies and mechanistic LBP research. Antibiotic-conditioned mice have a residual microbiome after depletion, offer faster setup, and are suitable when a fully axenic system is not required. Both receive human donor FMT to establish a humanized microbiome colonization background. Creative Biolabs offers both platforms and will recommend the right choice at project scoping.

We use 16S rRNA gene sequencing on recipient mouse fecal samples collected at days 7 and 14 post-transfer. Key QC metrics are alpha-diversity, donor-to-recipient Bray-Curtis similarity, and absence of contaminating species. A formal colonization quality report is issued based on these metrics — and the study does not advance to dosing unless engraftment meets predefined thresholds.

Yes. Clients may supply fresh or cryopreserved donor material processed under anaerobic conditions. Alternatively, we can source curated human donor samples matching your study criteria — healthy controls, specific disease states, or defined dietary backgrounds. In either case, the input inoculum is profiled by 16S sequencing and archived before use.

Core endpoints are defined at project scoping based on your study question and test article — common choices include gut immune markers, SCFA measurement, or histopathology scoring. Advanced readouts (metabolomics, full immune profiling, multi-omics integration) are available as optional add-ons and priced separately. We will discuss the right combination at your project kickoff call.

A standard study — colonization, treatment, endpoint collection, sequencing, and reporting — runs 10 to 16 weeks from project kickoff to final report delivery. Shorter exploratory designs can be completed in 6 to 8 weeks. Timelines and milestones are confirmed at project scoping.